Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade.
Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade.
复制标题
DOI:
10.1016/j.cell.2013.11.012
复制
发表时间:
2013-12-05
期刊:
影响因子:
64.5
通讯作者:
Sawyers CL
中科院分区:
文献类型:
--
作者:
Arora VK;Schenkein E;Murali R;Subudhi SK;Wongvipat J;Balbas MD;Shah N;Cai L;Efstathiou E;Logothetis C;Zheng D;Sawyers CL
The treatment of advanced prostate cancer has been transformed by novel antiandrogen therapies such as enzalutamide. Here we identify induction of glucocorticoid receptor (GR) expression as a common feature of drug resistant tumors in a credentialed preclinical model, a finding also confirmed in patient samples. GR substituted for the androgen receptor (AR) to activate a similar but distinguishable set of target genes and was necessary for maintenance of the resistant phenotype. The GR agonist dexamethasone was sufficient to confer enzalutamide resistance whereas a GR antagonist restored sensitivity. Acute AR inhibition resulted in GR upregulation in a subset of prostate cancer cells due to relief of AR-mediated feedback repression of GR expression. These findings establish a novel mechanism of escape from AR blockade through expansion of cells primed to drive AR target genes via an alternative nuclear receptor upon drug exposure.
登录
查看更多内容
影响因子:
7.7
作者:
Balbas MD;Evans MJ;Hosfield DJ;Wongvipat J;Arora VK;Watson PA;Chen Y;Greene GL;Shen Y;Sawyers CL
通讯作者:
Sawyers CL
影响因子:
82.9
作者:
Chen, CD;Welsbie, DS;Sawyers, CL
通讯作者:
Sawyers, CL
影响因子:
28.2
作者:
Korpal, Manav;Korn, Joshua M.;Zhu, Ping
通讯作者:
Zhu, Ping
影响因子:
45.3
作者:
Efstathiou, Eleni;Titus, Mark;Logothetis, Christopher J.
通讯作者:
Logothetis, Christopher J.
影响因子:
5.3
作者:
Klokk, Tove I.;Kurys, Piotr;Saatcioglu, Fahri
通讯作者:
Saatcioglu, Fahri